<DOC>
	<DOCNO>NCT01857011</DOCNO>
	<brief_summary>The purpose study determine whether intravenous oral iron effective treatment postoperative anemia iron deficiency patient submit postbariatric abdominoplasty .</brief_summary>
	<brief_title>Iron Supplementation Acute Anemia After Postbariatric Abdominoplasty</brief_title>
	<detailed_description>Multicenter open randomize clinical trial allocation ratio 1 : 1 . 56 adult patient undergo post- bariatric abdominoplasty evaluate . The study group receive 200 mg intravenous iron immediate postoperative period second application day 1 postoperatively . The control group receive 100 mg oral iron twice daily 8 week . Haematological variable , iron 's profile , quality life ( SF -36 FACT- An ) adverse event assess preoperatively first , fourth eighth week postoperatively .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric oxide , saccharated</mesh_term>
	<mesh_term>Teferrol</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Women 18 55 year Prior open laparoscopic standard limb Roux Y gastric bypass BMI &lt; 32 kg/m2 Stability weight loss least 6 month grade 3 abdominal deformity Pittsburgh scale Illiterate Current smoke Prior IV iron use last 3 month Uncontrolled systemic disease Hemoglobin &lt; 11 g/dL Ferritin &lt; 11 ng/mL Ferritin &gt; 100 ng/mL transferrin saturation &lt; 16 % transferrin saturation &gt; 50 % B12 &lt; 210 pg/mL Folic Acid &lt; 3.3 ng/mL Albumin &lt; 2 g/dL C reactive protein &gt; 5 mg/L Prior Anaphylactic reaction IV iron</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Anemia , Iron-Deficiency</keyword>
	<keyword>bariatric surgery</keyword>
	<keyword>abdominoplasty</keyword>
	<keyword>surgery , plastic</keyword>
	<keyword>iron</keyword>
</DOC>